Cyclerion Therapeutics (NASDAQ:CYCN) Shares Up 13%

Cyclerion Therapeutics Inc (NASDAQ:CYCN) shares shot up 13% during trading on Tuesday . The stock traded as high as $14.32 and last traded at $13.90, 168,900 shares were traded during trading. A decline of 3% from the average session volume of 173,725 shares. The stock had previously closed at $12.30.

Separately, Credit Suisse Group began coverage on shares of Cyclerion Therapeutics in a research report on Monday, June 3rd. They set a “neutral” rating for the company.

The company has a debt-to-equity ratio of 0.51, a quick ratio of 6.60 and a current ratio of 6.60. The business’s 50-day moving average is $9.49.

Cyclerion Therapeutics (NASDAQ:CYCN) last announced its quarterly earnings data on Monday, August 12th. The company reported ($1.18) EPS for the quarter, missing the consensus estimate of ($0.84) by ($0.34). The business had revenue of $1.63 million for the quarter.

Cyclerion Therapeutics Company Profile (NASDAQ:CYCN)

There is no company description available for Cyclerion Therapeutics Inc

See Also: Swap

Receive News & Ratings for Cyclerion Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cyclerion Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.